Alnylam Pharmaceuticals announces proposed public offering of common stock
Alnylam announced the commencement of an underwritten public offering of 5,000,000 shares of its common stock. Alnylam granted underwriter a 30-day option to purchase up to an additional 750,000 shares of its common stock . May 23, 2017